Together, our data indicate that Cdc20 is involved in DLBCL and MCL pathogenesis, thus supporting the preclinical testing of APC/C targeting in these aggressive B-cell NHLs. This evidence concerns the gene CDC20 and diffuse large B-cell lymphoma.